PETAL Consortium members are actively advancing research in T-cell lymphoma through a diverse portfolio of clinical trials.
Below is a selection of studies that our collaborators are leading or participating in to improve outcomes and expand therapeutic options for patients.
PETAL Consortium members are actively advancing research in T-cell lymphoma through a diverse portfolio of clinical trials.
Below is a selection of studies that our collaborators are leading or participating in to improve outcomes and expand therapeutic options for patients.
For a more comprehensive list of ongoing studies and detailed trial information, please visit ClinicalTrials.gov
For a more comprehensive list of ongoing studies and detailed trial information, please visit ClinicalTrials.gov
Large granular lymphocytic leukemia is a distinct subtype of T-cell lymphoma that typically presents in the blood, rather than primarily affecting the lymph nodes or solid organs.
